Sun Pharmaceutical Industries Base Case Target Achieved
Authored By Prime Research | Published at: Jul 9, 2026 12:52 PM IST
Open Free Demat Account
In our pick of the week report dated Mar 15, 2026, we had recommended to buy Sun Pharmaceutical Industries Ltd in the band of Rs 1781-1814 band and add on dips to Rs 1645-1664 band for base case target of Rs 1933 and bull case target of Rs 2052 over the next 4 quarters.
Today, the stock hit a high of Rs 1952, thereby achieved base case target of Rs 1933, yielding a return of 8%.
Disclaimer
At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Join Us
Add as preferred source on Google
